Skip to content

Clinical trials

Completed Phase 2 Movement Disorders trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Movement Disorders Phase: Phase 2 Status: Completed Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20052
20061
20073
20091
20102
20112
20123
20151
20171
20202
20214
20222
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed27

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals4
Jazz Pharmaceuticals3
National Institute of Neurological Disorders and Stroke (NINDS)3
Alterity Therapeutics2
Merck Sharp & Dohme LLC2
Praxis Precision Medicines2
Alkahest, Inc.1
Joshua Woolley, MD, PhD1
Juvantia Pharma Ltd1
Kyowa Kirin, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Movement Disorders27
Parkinson Disease15
Essential Tremor7
Dyskinesias6
Neurodegenerative Diseases6
Brain Diseases4
Central Nervous System Diseases4
Parkinsonian Disorders4
Tremor3
Basal Ganglia Diseases2

Trials

Showing 1 to 25 of 27. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.